Abstract | BACKGROUND:
Huntington's Disease (HD) is a hereditary, progressive neurodegenerative disorder characterised by both neurological and systemic symptoms. In HD, immune changes can be observed before the onset of overt clinical features raising the possibility that inflammatory markers in plasma could be used to track disease progression. It has previously been demonstrated that a widespread, progressive innate immune response is detectable in plasma throughout the course of HD. OBJECTIVE: The aim of the present study was to investigate the potential of several components of inflammation and innate immunity as plasma biomarkers in HD. METHODS: We utilised antibody-based detection technologies as well as mass spectrometric quantification, multiple reaction monitoring (MRM-MS). RESULTS: CONCLUSIONS: Although only C-reactive protein was found to be reduced in early HD, some of the inflammatory markers measured correlated with clinical measures.
|
Authors | Edina Silajdžić, Melinda Rezeli, Ákos Végvári, Nayana Lahiri, Ralph Andre, Anna Magnusson-Lind, Rajasree Nambron, Eirini Kalliolia, György Marko-Varga, Thomas T Warner, Thomas Laurell, Sarah J Tabrizi, Maria Björkqvist |
Journal | Journal of Huntington's disease
(J Huntingtons Dis)
Vol. 2
Issue 1
Pg. 125-34
( 2013)
ISSN: 1879-6397 [Print] Netherlands |
PMID | 25063434
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- C-Reactive Protein
|
Topics |
- Adult
- Aged
- Biomarkers
(blood)
- C-Reactive Protein
(analysis, immunology)
- Chromatography, Liquid
- Female
- Humans
- Huntington Disease
(blood, immunology)
- Inflammation
(blood, immunology)
- Male
- Middle Aged
- Tandem Mass Spectrometry
- Young Adult
|